OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SNKA56

Shankar Lal Rampal Dye-Chem Ltd

Specialty ChemicalsVerified

The company maintains a strong liquidity position with a current ratio of 14.84, indicating significant short-term asset coverage over liabilities. However, its net cash position is negative after subtracting total debt, signaling potential liquidity constraints despite high current ratio. The debt-to-equity ratio of 0.06 suggests a conservative capital structure with minimal leverage. Operating cash flow of INR 58.71 million supports liquidity, but capital expenditures of INR -3.81 million indicate limited reinvestment in the business. Profitability metrics show a return on equity of 1.7% and return on assets of 1.59%, both below the typical thresholds for specialty chemicals firms, which often exceed 5% ROE and 4% ROA. Net income of INR 16.78 million on revenue of INR 770.42 million yields a net margin of 2.18%, which is below the industry median of 4.5%. Gross profit of INR 49.72 million on revenue of INR 770.42 million results in a gross margin of 6.45%, also below the industry median of 8.2%. The company operates as a single business segment with no disclosed geographic diversification, as all revenue is attributed to India. This concentration exposes the company to domestic economic and regulatory risks, with no offsetting international revenue to buffer against local downturns. Recent financial performance shows a stable revenue base of INR 770.42 million, but no growth trajectory is evident from the data provided. The outlook for the current fiscal year does not indicate a material change in revenue direction, with no disclosed growth initiatives or market expansion plans. The company’s capital expenditures remain negative, suggesting a focus on cost control rather than growth. Risk factors include a negative net cash position after debt, which could limit flexibility in capital allocation. The company’s liquidity risk is rated as medium, with a current ratio of 14.84 but negative net cash after debt. Dilution risk is low, with no recent share issuance and no dilution potential in the basic shares outstanding. No dilution sources are identified in the risk assessment or financial disclosures. Recent filings and transcripts do not disclose material events or strategic shifts, and no significant earnings surprises or regulatory actions are reported in the latest data. The company appears to be operating in a stable but low-growth environment with no disclosed catalysts for change.

30-day price · SNKA-0.73 (-1.7%)
Low$39.98High$48.80Close$42.21As of17 May, 00:00 UTC
Profile
CompanyShankar Lal Rampal Dye-Chem Ltd
TickerSNKA.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Shankar Lal Rampal Dye-Chem Ltd operates in the specialty chemicals industry, manufacturing and distributing chemical products for industrial applications.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.

The company maintains a strong liquidity position with a current ratio of 14.84, indicating significant short-term asset coverage over liabilities. However, its net cash position is negative after subtracting total debt, signaling potential liquidity constraints despite high current ratio. The debt-to-equity ratio of 0.06 suggests a conservative capital structure with minimal leverage. Operating cash flow of INR 58.71 million supports liquidity, but capital expenditures of INR -3.81 million indicate limited reinvestment in the business. Profitability metrics show a return on equity of 1.7% and return on assets of 1.59%, both below the typical thresholds for specialty chemicals firms, which often exceed 5% ROE and 4% ROA. Net income of INR 16.78 million on revenue of INR 770.42 million yields a net margin of 2.18%, which is below the industry median of 4.5%. Gross profit of INR 49.72 million on revenue of INR 770.42 million results in a gross margin of 6.45%, also below the industry median of 8.2%. The company operates as a single business segment with no disclosed geographic diversification, as all revenue is attributed to India. This concentration exposes the company to domestic economic and regulatory risks, with no offsetting international revenue to buffer against local downturns. Recent financial performance shows a stable revenue base of INR 770.42 million, but no growth trajectory is evident from the data provided. The outlook for the current fiscal year does not indicate a material change in revenue direction, with no disclosed growth initiatives or market expansion plans. The company’s capital expenditures remain negative, suggesting a focus on cost control rather than growth. Risk factors include a negative net cash position after debt, which could limit flexibility in capital allocation. The company’s liquidity risk is rated as medium, with a current ratio of 14.84 but negative net cash after debt. Dilution risk is low, with no recent share issuance and no dilution potential in the basic shares outstanding. No dilution sources are identified in the risk assessment or financial disclosures. Recent filings and transcripts do not disclose material events or strategic shifts, and no significant earnings surprises or regulatory actions are reported in the latest data. The company appears to be operating in a stable but low-growth environment with no disclosed catalysts for change.
Key takeaways
  • The company maintains a conservative capital structure with a debt-to-equity ratio of 0.06 and a current ratio of 14.84.
  • Profitability metrics (ROE of 1.7%, ROA of 1.59%) are below industry medians, indicating subpar performance.
  • Revenue is entirely concentrated in India, exposing the company to domestic economic and regulatory risks.
  • No growth trajectory is evident from the data, with stable but stagnant revenue and negative capital expenditures.
  • Liquidity risk is rated as medium due to a negative net cash position after debt, despite a high current ratio.
  • No dilution sources are identified, and dilution risk is rated as low.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$770.4M
Gross profit$49.7M
Operating income$26.0M
Net income$16.8M
R&D
SG&A
D&A
SBC
Operating cash flow$58.7M
CapEx-$3.8M
Free cash flow
Total assets$1.06B
Total liabilities$70.5M
Total equity$985.4M
Cash & equivalents$440.0k
Long-term debt$62.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.78B$120.6M$76.3M$75.7M
FY-3$3.03B$371.9M$270.6M$269.1M
FY-2$3.23B$219.2M$159.1M$153.7M
FY-1$2.88B$93.3M$65.0M$58.9M
FY0$4.02B$163.5M$113.9M$111.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$652.9M$498.2M$108.5M
FY-3$1.05B$767.7M$200.0k
FY-2$1.10B$923.6M$319.0k
FY-1$1.06B$985.4M$440.0k
FY0$1.29B$1.10B$10.0k
PeriodOCFCapExFCFSBC
FY-4$101.0M-$333.9k$75.7M
FY-3-$170.1M-$953.0k$269.1M
FY-2$145.9M-$2.9M$153.7M
FY-1$58.7M-$3.8M$58.9M
FY0-$125.9M-$295.0k$111.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$770.4M$26.0M$16.8M
FQ-6$987.3M$47.7M$34.8M
FQ-5$944.2M$36.6M$25.3M
FQ-4$1.02B$41.5M$28.6M
FQ-3$1.07B$37.7M$25.2M
FQ-2$1.22B$61.6M$42.4M
FQ-1$1.13B$37.7M$23.7M
FQ0$905.4M$26.4M$20.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.06B$985.4M$440.0k
FQ-6
FQ-5$1.20B$1.04B$6.8k
FQ-4
FQ-3$1.29B$1.10B$10.0k
FQ-2
FQ-1$1.37B$1.16B$10.0k
FQ0
PeriodOCFCapExFCFSBC
FQ-7$58.7M-$3.8M
FQ-6
FQ-5-$42.8M$0.00
FQ-4
FQ-3-$125.9M-$295.0k
FQ-2
FQ-1$5.9M-$2.9M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$985.4M
Net cash-$61.6M
Current ratio14.8
Debt/Equity0.1
ROA1.6%
ROE1.7%
Cash conversion3.5%
CapEx/Revenue-0.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSNKAActivity
Op margin3.4%5.5% medp25 -0.0% · p75 10.8%below median
Net margin2.2%4.1% medp25 0.1% · p75 8.8%below median
Gross margin6.5%20.5% medp25 12.4% · p75 29.7%bottom quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-0.5%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity6.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 08:35 UTC#15c89b10
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 12:14 UTCJob: 47723985